EFFECTIVE TUMOR IMMUNOTHERAPY USING BONE MARROW (BM)-DERIVED DENDRITIC CELLS (DCS) GENETICALLY ENGINEERED TO EXPRESS INTERLEUKIN 12
- 1 September 1997
- journal article
- abstracts
- Published by Wolters Kluwer Health in Journal of Immunotherapy
- Vol. 20 (5) , 419
- https://doi.org/10.1097/00002371-199709000-00090
Abstract
No abstract availableThis publication has 0 references indexed in Scilit: